Close menu




September 30th, 2025 | 07:40 CEST

Antimony Resources, Rheinmetall, Novo Nordisk – Something is in the air!

  • Mining
  • antimony
  • Defense
  • Biotechnology
Photo credits: pixabay.com

Sufficient access to raw materials is crucial for any economy. The EU has compiled a list of 34 critical raw materials. How critical a raw material is classified depends on two parameters: "economic importance" and "supply risk." This list also includes a little-known but very important metalloid – antimony. The price of antimony skyrocketed at the end of 2024 in the wake of China's export ban. There are still exciting investment opportunities in this area.

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: ANTIMONY RESOURCES CORP | CA0369271014 , RHEINMETALL AG | DE0007030009 , NOVO NORDISK A/S | DK0062498333

Table of contents:


    David Elsley, CEO, Cardiol Therapeutics Inc.
    "[...] As a company dedicated to developing treatments for rare heart diseases, we see this as an opportune moment to contribute to the fight against heart disease and make meaningful strides in improving heart health worldwide. [...]" David Elsley, CEO, Cardiol Therapeutics Inc.

    Full interview

     

    Antimony Resources – Still flying under the radar of investors

    Antimony is versatile and in high demand: its applications as a flame retardant, in photovoltaics, defense, semiconductors, and energy storage highlight its importance. As with many other critical metals and rare earths, China dominates global supply. At the end of last year, the country imposed a global export ban. This shines a spotlight on future producers, such as Antimony Resources.

    The Canadians have the option to acquire the Bald Hill property in southern New Brunswick, Canada. Previous drilling has identified antimony over a length of more than 700 m and a depth of 400 m with an average thickness of over 3 m and a grade of 3% to 4% antimony (Sb). This distinguishes Bald Hill as a first-class, high-grade antimony deposit.

    The current drilling program, which could give the stock a significant boost, is divided into several phases. A total of at least 6,000 meters of drilling is to be completed. Phase 1 at Bald Hill has already delivered good results. Significant high-grade antimony deposits were intersected in over 75% of the drill holes. The previously defined main mineralization zone was also significantly expanded.

    The Company has now announced the start of the second phase of its drilling program, with two main priorities. The first is to extend the known antimony-bearing mineralization to the north and south and to expand the mineralization at depth. This trend has already been successfully demonstrated in Phase 1.

    The second priority is to drill at locations that demonstrate a connection between widely separated mineralization zones. The aim is to determine whether the mineralization is sufficiently continuous and whether sufficient data is available.

    Rheinmetall – Above the EUR 2000 mark for the first time

    As mentioned above, antimony plays an important role in the defense industry. This semi-metal increases the hardness and stability of lead and is therefore essential in the manufacture of ammunition and armor. Antimony is also used in high-tech weapons, night vision devices, and infrared sensors.

    German defense stocks continued their rally at the beginning of the week, reaching new all-time highs. Rheinmetall shares climbed slightly above the EUR 2,000 mark for the first time. Although the shares have already increased twentyfold since the start of the war in Ukraine, analysts at UBS and mwb research still see room for growth up to EUR 2,500.

    The enormous demand for weapon systems and ammunition continues to swell order books. The DAX-listed company recently announced that it would be supplying ammunition to Eastern Europe as a subcontractor to a company commissioned by the US government. The total value of the order is in the mid three-digit million range.

    Novo Nordisk – Negative analyst opinion weighs on the stock in the short term

    A significant downgrade by Morgan Stanley to "Underweight", coupled with a price target capped at EUR 40, weighed on the stock in the short term. Analysts expect minimal growth in revenue and profits next year and point to the Danish company's challenging competitive position.

    The shares are currently trading at around EUR 47 and have already priced in many negative factors. At first glance, the stock appears undervalued historically, but growth remains subdued. Investors are not missing out on anything yet and can monitor developments from the sidelines.


    If Antimony Resources' current drilling program proves successful, as initial data suggests, this could give the share price a significant boost. The market capitalization is just CAD 11 million. Rheinmetall is benefiting from sustained high demand and still has room for growth despite reaching an all-time high. A lot of negative factors are already priced into Novo Nordisk's share price.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by André Will-Laudien on September 30th, 2025 | 07:35 CEST

    High-tech super boom! 1,000% no problem—here is more from D-Wave, NetraMark and Palantir!

    • Biotechnology
    • AI
    • Digitization
    • hightech
    • computing
    • Software

    Artificial intelligence (AI) is currently revolutionizing drug development by analyzing enormous amounts of data in a very short time and making clinical trials much more targeted. Modern AI systems make it possible to select drug candidates with precision and predict the potential success of a therapy with a high degree of accuracy. Companies like NetraMark are already using these technologies profitably. Players such as D-Wave and Palantir are also among the pioneers of the new AI-driven economy and have seen their share prices rise by over 1,000%. Expectations for further growth are virtually limitless. The advent of quantum computer technology also marks the beginning of a new chapter in ultra-fast data processing. For forward-looking investors, this opens up attractive entry opportunities in dynamically expanding future markets. Those who bet on the right players early on can benefit from this change to an above-average extent.

    Read

    Commented by Stefan Feulner on September 30th, 2025 | 07:30 CEST

    Barrick Mining, Desert Gold, Aura Minerals – Epic rally with no end in sight

    • Mining
    • Gold
    • PreciousMetals
    • Investments

    The price of gold has once again reached a new all-time high, amid a global environment fraught with uncertainty. Driven by geopolitical tensions, simmering inflation fears, and record-high debt levels in many countries, the precious metal continues to take center stage. Central banks are buying more gold than they have in decades, while investors are rushing into physical gold, ETFs, and mining stocks. Experts expect another bull run, even beyond the magic mark of USD 4,000 per ounce.

    Read

    Commented by Nico Popp on September 30th, 2025 | 07:25 CEST

    Is the industrial heart of Europe dying? Mercedes-Benz, Porsche, AJN Resources

    • Mining
    • Gold
    • PreciousMetals
    • Electromobility

    Uncertainty in Germany is greater than ever: Increasingly, companies in the automotive industry are cutting jobs. According to industry experts at EY, around 51,100 jobs were lost in the automotive industry within a year, corresponding to around 7% of all jobs. Companies in other sectors are also making cuts. Most recently, Lufthansa also laid off staff. This bad news is accompanied by a worrying mood of doom and gloom among the German population – especially in the traditionally wealthy southwest of the country. In this article, we explain how the industrial giants Porsche and Mercedes-Benz are faring and why more and more investors are turning their attention to gold stocks as a result.

    Read